[EN] TRIAZOLO[1,5-A]PYRIMIDINES AND PYRAZOLO[1,5-A]PYRIMIDINES USEFUL AS A2A ADENOSIN E RECEPTOR ANTAGONISTS [FR] TRIAZOLO[1,5-A]PYRIMIDINES ET PYRAZOLO[1,5-A]PYRIMIDINES ET PROCEDES DE PREPARATION ET D'UTILISATION DE CELLES-CI
[EN] TRIAZOLO[1,5-A]PYRIMIDINES AND PYRAZOLO[1,5-A]PYRIMIDINES AND METHODS OF MAKING AND USING THE SAME<br/>[FR] TRIAZOLO[1,5-A]PYRIMIDINES ET PYRAZOLO[1,5-A]PYRIMIDINES ET PROCEDES DE PREPARATION ET D'UTILISATION DE CELLES-CI
申请人:BIOGEN IDEC INC
公开号:WO2004092171A2
公开(公告)日:2004-10-28
The invention is based on the discovery that compounds of formula (I) possess unexpectedly high affinity for the A2a adenosine receptor, and can be useful as antagonists thereof for preventing and/or treating numerous diseases, including Parkinson's disease. In one embodiment, the invention features a compound of formula (I) .
[EN] TRIAZOLO[1,5-A]PYRIMIDINES AND PYRAZOLO[1,5-A]PYRIMIDINES USEFUL AS A2A ADENOSIN E RECEPTOR ANTAGONISTS<br/>[FR] TRIAZOLO[1,5-A]PYRIMIDINES ET PYRAZOLO[1,5-A]PYRIMIDINES ET PROCEDES DE PREPARATION ET D'UTILISATION DE CELLES-CI